BACKGROUND: The use of brain natriuretic peptide (BNP) in the evaluation of the dyspneic pediatric patient is increasingly supported for infants and newborns with congenital heart disease.

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

The latter enzyme is responsible for the breakdown of the three natriuretic peptides -- atrial natriuretic peptide, brain-derived natriuretic peptide, and C-type natriuretic peptide -- and bradykinin.

SAN DIEGO -- Finerenone (Kerendia) yielded minimal renal benefit in patients with heart failure with mildly reduced or ...

BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience ...

Medically reviewed by Christopher Lee, MD Systolic congestive heart failure, or systolic heart failure, is a type of heart ...

Dr. Pandey and his colleagues found that combining these risk assessment strategies sequentially by adding a second step—such as giving low-risk patients by clinical risk score a blood test for ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

Background Previous research has suggested a heightened risk of acute myocarditis after COVID-19 infection. However, it is ...